Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Medtronic gains regulatory wins for latest cardiac ablation software

30 September 2026 · By · Wire by Fusion42

Published

30 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 30 September 2026 · Fusion42 review

Medtronic has secured FDA clearance and CE marks for its Affera Prism-2 cardiac mapping software and PulseSelect ProxBox adapter with proximity indicator, enhancing its cardiac ablation product portfolio and supporting significant revenue growth in its cardiovascular segment.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 30 Sep 2026 and 1 Oct 2026.

◆ ◆ The Wire takeaway

Medtronic's regulatory wins open doors for you in cardiac ablation software; prepare to engage clinicians now as demand for enhanced mapping tools grows alongside pulsed field ablation's adoption.

◆ Coverage

2 sources · first reported 30 Sep 2026 · latest 1 Oct 2026

◆ Related on Wire

◆ Topics

Medtechregulatory-clearancecardiac-ablationmedtronicmedical-softwarecardiovascular